These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 22720992

  • 1. Effect of oral administration of pimobendan in cats with heart failure.
    Gordon SG, Saunders AB, Roland RM, Winter RL, Drourr L, Achen SE, Hariu CD, Fries RC, Boggess MM, Miller MW.
    J Am Vet Med Assoc; 2012 Jul 01; 241(1):89-94. PubMed ID: 22720992
    [Abstract] [Full Text] [Related]

  • 2. Use of pimobendan in 170 cats (2006-2010).
    Macgregor JM, Rush JE, Laste NJ, Malakoff RL, Cunningham SM, Aronow N, Hall DJ, Williams J, Price LL.
    J Vet Cardiol; 2011 Dec 01; 13(4):251-60. PubMed ID: 22030289
    [Abstract] [Full Text] [Related]

  • 3. Case-control study of the effects of pimobendan on survival time in cats with hypertrophic cardiomyopathy and congestive heart failure.
    Reina-Doreste Y, Stern JA, Keene BW, Tou SP, Atkins CE, DeFrancesco TC, Ames MK, Hodge TE, Meurs KM.
    J Am Vet Med Assoc; 2014 Sep 01; 245(5):534-9. PubMed ID: 25148095
    [Abstract] [Full Text] [Related]

  • 4. Effect of pimobendan on the incidence of arrhythmias in small breed dogs with myxomatous mitral valve degeneration.
    Lake-Bakaar GA, Singh MK, Kass PH, Griffiths LG.
    J Vet Cardiol; 2015 Jun 01; 17(2):120-8. PubMed ID: 26007710
    [Abstract] [Full Text] [Related]

  • 5. Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy.
    Oldach MS, Ueda Y, Ontiveros ES, Fousse SL, Visser LC, Stern JA.
    BMC Vet Res; 2021 Feb 23; 17(1):89. PubMed ID: 33622315
    [Abstract] [Full Text] [Related]

  • 6. Use of pimobendan in the management of heart failure.
    Fuentes VL.
    Vet Clin North Am Small Anim Pract; 2004 Sep 23; 34(5):1145-55. PubMed ID: 15325474
    [Abstract] [Full Text] [Related]

  • 7. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.
    Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Ablad B, Bussadori CM, Glaus T, Kovacević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir AV, O'Sullivan ML, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R.
    J Vet Intern Med; 2008 Sep 23; 22(5):1124-35. PubMed ID: 18638016
    [Abstract] [Full Text] [Related]

  • 8. Effect of pimobendan on the clinical outcome and survival of cats with non-taurine responsive dilated cardiomyopathy.
    Hambrook LE, Bennett PF.
    J Feline Med Surg; 2012 Apr 23; 14(4):233-9. PubMed ID: 22412159
    [Abstract] [Full Text] [Related]

  • 9. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial.
    Boswood A, Häggström J, Gordon SG, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Watson P.
    J Vet Intern Med; 2016 Nov 23; 30(6):1765-1779. PubMed ID: 27678080
    [Abstract] [Full Text] [Related]

  • 10. A review of the pharmacology and clinical uses of pimobendan.
    Boyle KL, Leech E.
    J Vet Emerg Crit Care (San Antonio); 2012 Aug 23; 22(4):398-408. PubMed ID: 22928748
    [Abstract] [Full Text] [Related]

  • 11. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
    Häggström J, Lord PF, Höglund K, Ljungvall I, Jöns O, Kvart C, Hansson K.
    J Vet Intern Med; 2013 Aug 23; 27(6):1452-62. PubMed ID: 24128373
    [Abstract] [Full Text] [Related]

  • 12. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study.
    Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Åblad B, Bussadori CM, Glaus T, Kovačević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir A, Lynne O'Sullivan M, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R.
    J Vet Intern Med; 2013 Aug 23; 27(6):1441-51. PubMed ID: 24010489
    [Abstract] [Full Text] [Related]

  • 13. Effects of pimobendan in cats with hypertrophic cardiomyopathy and recent congestive heart failure: Results of a prospective, double-blind, randomized, nonpivotal, exploratory field study.
    Schober KE, Rush JE, Luis Fuentes V, Glaus T, Summerfield NJ, Wright K, Lehmkuhl L, Wess G, Sayer MP, Loureiro J, MacGregor J, Mohren N.
    J Vet Intern Med; 2021 Mar 23; 35(2):789-800. PubMed ID: 33543810
    [Abstract] [Full Text] [Related]

  • 14. [Reduction in left ventricular volume and improvement in hemodynamics following intravenous administration of pimobendan (UDGG 115 BS) in dilated cardiomyopathy].
    Permanetter B, Sebening H, Busch U, Lutilsky L.
    Z Kardiol; 1990 Aug 23; 79(8):565-72. PubMed ID: 2220013
    [Abstract] [Full Text] [Related]

  • 15. Pimobendan in heart failure therapy--a silver bullet?
    Gordon SG, Miller MW, Saunders AB.
    J Am Anim Hosp Assoc; 2006 Aug 23; 42(2):90-3. PubMed ID: 16527909
    [Abstract] [Full Text] [Related]

  • 16. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy.
    O'Grady MR, Minors SL, O'Sullivan ML, Horne R.
    J Vet Intern Med; 2008 Aug 23; 22(4):897-904. PubMed ID: 18537880
    [Abstract] [Full Text] [Related]

  • 17. Pimobendan and its use in treating canine congestive heart failure.
    Bowles D, Fry D.
    Compend Contin Educ Vet; 2011 Nov 23; 33(11):E1. PubMed ID: 22101450
    [Abstract] [Full Text] [Related]

  • 18. Retrospective evaluation of the safety and tolerability of pimobendan in cats with obstructive vs nonobstructive cardiomyopathy.
    Ward JL, Kussin EZ, Tropf MA, Tou SP, DeFrancesco TC, Keene BW.
    J Vet Intern Med; 2020 Nov 23; 34(6):2211-2222. PubMed ID: 33026124
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure.
    Mizuno M, Yamano S, Chimura S, Hirakawa A, Takusagawa Y, Sawada T, Maetani S, Takahashi A, Mizuno T, Harada K, Shinoda A, Uchida S, Takeuchi J, Mizukoshi T, Endo M, Uechi M.
    J Vet Med Sci; 2017 Jan 20; 79(1):29-34. PubMed ID: 27644192
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and pharmacodynamics of enantiomers of pimobendan in patients with dilated cardiomyopathy and congestive heart failure after single and repeated oral dosing.
    Chu KM, Shieh SM, Hu OY.
    Clin Pharmacol Ther; 1995 Jun 20; 57(6):610-21. PubMed ID: 7781260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.